LOETTE Tablet Ref.[50611] Active ingredients: 17 alpha-Ethinylestradiol Levonorgestrel

Source: Medicines and Medical Devices Safety Authority (NZ)  Revision Year: 2018  Publisher: Pfizer New Zealand Limited, P O Box 3998, Auckland, New Zealand, 1140, Toll Free Number: 0800 736 363

Product name and form

LOETTE 20 µg and 100 µg tablets.

Pharmaceutical Form

Each LOETTE calendar blister pack contains 21 pink active tablets and 7 white inactive tablets.

Qualitative and quantitative composition

Each tablet contains 20 µg Ethinylestradiol and 100 µg Levonorgestrel.

Excipients with known effects: Lactose monohydrate.

For the full list of excipients, see section 6.1.

Active Ingredient Description
17 alpha-Ethinylestradiol

Ethinylestradiol is chemically and biologically identical to endogenous human oestradiol. It substitutes for the loss of estrogen production in menopausal women, and alleviates menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy.

Levonorgestrel

The precise mode of action of levonorgestrel as an emergency contraceptive is not known. At the recommended regimen, levonorgestrel is thought to work mainly by preventing ovulation and fertilisation if intercourse has taken place in the preovulatory phase, when the likelihood of fertilisation is the highest.

List of Excipients

Each pink active tablet contains 100 µg levonorgestrel and 20 µg ethinylestradiol and the excipients: microcrystalline cellulose, lactose monohydrate, polacrilin potassium, magnesium stearate, macrogol 1450, glycol montanate and Opadry YS-1-14587-A Pale Pink.

Each white inactive tablet contains lactose monohydrate, microcrystalline cellulose, magnesium stearate, polacrilin potassium, macrogol 1500, glycol montanate and Opadry Y-5-18024-A White (US version).

Pack sizes and marketing

One-month pack containing one blister tray or a three-month pack containing 3 blister trays. Each blister tray contains 21 pink active tablets, each containing levonorgestrel 100 µg and ethinylestradiol 20 µg, and 7 white inactive tablets.

Marketing authorization holder

Pfizer New Zealand Limited, P O Box 3998, Auckland, New Zealand, 1140, Toll Free Number: 0800 736 363

Marketing authorization dates and numbers

13 August 1998

Drugs

Drug Countries
LOETTE Austria, Estonia, Spain, Hong Kong, Lithuania, New Zealand, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.